ArticleEvaluation of Serum Programmed Cell Death–1 (PD-1) in Psoriasis Vulgaris: A Case-control Study
ArticleEvaluation of Serum Programmed Cell Death–1 (PD-1) in Psoriasis Vulgaris: A Case-control Study
ArticleAssessment of Serum MicroRNA-221-3p and Tumor Necrosis Factor-α Levels in Patients with Chronic Plaque Psoriasis: A case-control Study
ArticleAssessment of Serum MicroRNA-221-3p and Tumor Necrosis Factor-α Levels in Patients with Chronic Plaque Psoriasis: A case-control Study
ArticleInterleukin-23 and its Receptor Expression (IL-23R) in Psoriatic and Psoriatic Arthritis Patients
ArticleInterleukin-23 and its Receptor Expression (IL-23R) in Psoriatic and Psoriatic Arthritis Patients
ArticleRole of Interleukin-18, Tumor Necrosis Factor-α, Osteopontin, Paraoxonase and Lipoprotein (a) in Psoriasis Pathogenicity.
ArticleRole of Interleukin-18, Tumor Necrosis Factor-α, Osteopontin, Paraoxonase and Lipoprotein (a) in Psoriasis Pathogenicity.
ArticleComprehensive Insights into Psoriasis: Disease Types, Underlying Mechanisms, and Effective Treatments
ArticleComprehensive Insights into Psoriasis: Disease Types, Underlying Mechanisms, and Effective Treatments